🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Tablet(s) Serving Size
60 Servings
Botanical Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

Calories
Total Carbohydrates
1 Gram(s) (1% DV)
Sodium
10 mg (1% DV)
Cruciferous Plus Blend
525 mg

Other Ingredients

Microcrystalline Cellulose Calcium Carbonate Rice Starch Sodium Croscarmellose Stearic Acid Silicon Dioxide Hydroxypropyl Methylcellulose Simethicone Natural Color

Label Claims — Verification

All Other
Structure/Function

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Suggested use: 1 tablet daily with food.

⚠️ Warnings & Precautions

Packaged with safety seal

Contains soy.

🧪 Formulation Notes

Supports enzyme activity linked to normal cell growth and renewal, especially of breast and prostate tissues with sulforaphane and indolecarbinol (from broccoli and other crucifer extracts) and D-limonene (from oranges). Soy (from high isoflavone soy milk concentrate) provides isoflavones (e.g. genistein) that helps maintain healthy hormonal activity.

NeoLife products use only Gmo-free ingredients

Protective phytonutrients from whole foods

Made in U.S.A.

Additional Information

Store in a cool, dry place away from direct sunlight.

Based in nature

Not sold in retail stores. Available exclusively from NeoLife promoters.

SAB Scientific Advisory Board NeoLife Scientific Advisory Board

Product Details

UPC / SKU 3301s
DSLD Entry Date 2023-12-14
Product Type Botanical
Form Tablet or Pill
DSLD ID 303255
Data Updated 2026-04-11

Research Evidence

We're building the evidence profile for this product's ingredients.

Our team is working to connect every product on the American market with peer-reviewed research. Check back soon for evidence-backed analysis.